OTC · Financial Statements
Innovation Pharmaceuticals Inc. (IPIX) Financial Statements
$0.00
OTC: IPIX
Market Cap $1.04M
Overview Financials Dividend
Innovation Pharmaceuticals Inc. most recently reported annual revenue of $0, a net loss of $3.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2019 2020 2021 2022 2023
Revenue $0 $0 $0 $0 $0 Operating Profit $-6.0M $-5.0M $-9.0M $-7.0M $-3.0M Net Profit $-9.0M $-7.0M $-14.0M $-7.0M $-3.0M EPS $-0.05 $-0.03 $-0.04 $-0.01 $-0.01 Op Margin — -1095.7% — -38450.0% —
Balance Sheet (USD)
Metric 2019 2020 2021 2022 2023
Total Assets $4.0M $9.0M $14.0M $10.0M $8.0M Total Liabilities $8.0M $8.0M $7.0M $6.0M $5.0M Cash $1.0M $6.0M $10.0M $4.0M $2.0M Borrowings $2.0M $2.0M $2.0M $1.0M $1.0M
Cash Flow (USD)
Metric 2019 2020 2021 2022 2023
Operating Cash Flow $-6.0M $-4.0M $-9.0M $-6.0M $-2.0M Investing Cash Flow $0 $0 $0 $-8.0M $0 Financing Cash Flow $3.0M $10.0M $-1.0M $0 $0 Net Cash Flow $-2.0M $5.0M $4.0M $-6.0M $-2.0M Free Cash Flow $-6.0M $-4.0M $-10.0M $-6.0M $-2.0M
Valuation & Return Ratios
Metric Value PEG Ratio 0.00 EV / EBITDA -0.09 FCF Yield -208.93% Quick Ratio 0.33 Interest Coverage -54.58 Return 1Y 566.67% Return 3Y -88.24% Return 5Y —
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer .